The store will not work correctly when cookies are disabled.
N-(4-amino-3-(trifluoromethyl)phenyl)-4-tert-butylbenzenesulfonamide
ID: ALA4799103
PubChem CID: 162674533
Max Phase: Preclinical
Molecular Formula: C17H19F3N2O2S
Molecular Weight: 372.41
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: CC(C)(C)c1ccc(S(=O)(=O)Nc2ccc(N)c(C(F)(F)F)c2)cc1
Standard InChI: InChI=1S/C17H19F3N2O2S/c1-16(2,3)11-4-7-13(8-5-11)25(23,24)22-12-6-9-15(21)14(10-12)17(18,19)20/h4-10,22H,21H2,1-3H3
Standard InChI Key: NHCNWQVFTNLDJV-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 26 0 0 0 0 0 0 0 0999 V2000
36.2825 -4.7463 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
35.8780 -4.0406 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
35.4690 -4.7437 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
37.2963 -4.0405 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.2952 -4.8601 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.0032 -5.2690 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.7129 -4.8596 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.7101 -4.0369 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.0015 -3.6317 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.5885 -3.6321 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
35.1731 -3.6324 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.1766 -2.8146 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.4696 -2.4063 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.7610 -2.8151 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.7638 -3.6365 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.4714 -4.0412 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.4213 -5.2671 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
38.0030 -6.0862 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.2952 -6.4946 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
38.7107 -6.4950 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
37.9953 -6.9007 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
33.0527 -2.4076 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.3456 -2.8173 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.0514 -1.5904 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.3410 -1.9976 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 4 1 0
4 10 1 0
10 2 1 0
2 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 11 1 0
7 17 1 0
6 18 1 0
18 19 1 0
18 20 1 0
18 21 1 0
14 22 1 0
22 23 1 0
22 24 1 0
22 25 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 372.41 | Molecular Weight (Monoisotopic): 372.1119 | AlogP: 4.39 | #Rotatable Bonds: 3 |
Polar Surface Area: 72.19 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 8.40 | CX Basic pKa: 2.35 | CX LogP: 4.05 | CX LogD: 4.02 |
Aromatic Rings: 2 | Heavy Atoms: 25 | QED Weighted: 0.79 | Np Likeness Score: -1.62 |
References
1. Xu F,Zhao Y,Zhou H,Li C,Zhang X,Hou T,Qu L,Wei L,Wang J,Liu Y,Liang X. (2020) Synthesis and evaluation of 3-(4-(phenoxymethyl)phenyl)propanoic acid and N-phenylbenzenesulfonamide derivatives as FFA4 agonists., 30 (24): [PMID:33127539] [10.1016/j.bmcl.2020.127650] |